Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Debt

The Debt of Jinyu Bio-Technology Co (600201.SS) as of Oct 29, 2026 is 16.26 M CNY. In the previous year, Debt was 2.73 M CNY — a change of 494.56% (higher).

Debt

16.26 MCNY

YoY

494.56%

Last updated:

In 2024, Jinyu Bio-Technology Co's total debt was 16.26 M CNY, a 494.56% change from the 2.73 M CNY total debt recorded in the previous year.

The Jinyu Bio-Technology Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
2.58 M CNY
Jan 1, 2018
2.58 M CNY
Jan 1, 2019
40.08 M CNY
Jan 1, 2020
98.05 M CNY
Jan 1, 2021
776,328.00 CNY
Jan 1, 2022
10.85 M CNY
Jan 1, 2023
2.73 M CNY
Jan 1, 2024
16.26 M CNY
The Jinyu Bio-Technology Co Debt history
YEARDebtYoY
16.26 MCNY+494.56%
2.73 MCNY-74.80%
10.85 MCNY+1,298.10%
776,328.00CNY-99.21%
98.05 MCNY+144.63%
40.08 MCNY+1,453.49%
2.58 MCNY0.00%
2.58 MCNY+416.00%
500,000.00CNY0.00%
500,000.00CNY0.00%
500,000.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Jinyu Bio-Technology Co's Debt Structure

Jinyu Bio-Technology Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Jinyu Bio-Technology Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Jinyu Bio-Technology Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Jinyu Bio-Technology Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Debt of Jinyu Bio-Technology Co is 16.26 M CNY in 2024.

Debt of Jinyu Bio-Technology Co changed from 2.73 M CNY to 16.26 M CNY, representing a 494.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Jinyu Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Jinyu Bio-Technology Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Jinyu Bio-Technology Co